Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Next-morning driving performance after middle-of-the-night sublingual zolpidem
NL-OMON34606Active, not recruiting
- Sponsor
- Transcept Pharmaceuticals
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of zolpidem and zopiclone in Insomnia (4 arms), sponsored by Transcept Pharmaceuticals. Primary endpoint: Impaired drivers threshold >2.5 cm. Started Jun 2010; status: active, not recruiting.
02
Drugs
zolpidemzopiclone
03
Conditions
Insomnia
Beyond the preview
Go deeper on NL-OMON34606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34606.